BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18564136)

  • 1. Changes in the stage and surgical management of renal tumours during 1995-2005: an analysis of the Dutch national histopathology registry.
    Kümmerlin IP; ten Kate FJ; Wijkstra H; de la Rosette JJ; Laguna MP
    BJU Int; 2008 Sep; 102(8):946-51. PubMed ID: 18564136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in epidemiology and treatment of upper urinary tract tumours in the Netherlands 1995-2005: an analysis of PALGA, the Dutch national histopathology registry.
    Cauberg EC; Salomons MA; Kümmerlin IP; de Reijke TM; Zwinderman AH; de la Rosette JJ; Kate FJ; Laguna Pes MP
    BJU Int; 2010 Apr; 105(7):922-7. PubMed ID: 19804428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morbidity and clinical outcome of nephron-sparing surgery in relation to tumour size and indication.
    Patard JJ; Pantuck AJ; Crepel M; Lam JS; Bellec L; Albouy B; Lopes D; Bernhard JC; Guillé F; Lacroix B; De La Taille A; Salomon L; Pfister C; Soulié M; Tostain J; Ferriere JM; Abbou CC; Colombel M; Belldegrun AS
    Eur Urol; 2007 Jul; 52(1):148-54. PubMed ID: 17240036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm.
    Peycelon M; Hupertan V; Comperat E; Renard-Penna R; Vaessen C; Conort P; Bitker MO; Chartier-Kastler E; Richard F; Rouprêt M
    J Urol; 2009 Jan; 181(1):35-41. PubMed ID: 19012929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-evaluation of the Tumour-Node-Metastasis staging of locally advanced renal cortical tumours: absolute size (T2) is more significant than renal capsular invasion (T3a).
    Murphy AM; Gilbert SM; Katz AE; Goluboff ET; Sawczuk IS; Olsson CA; Benson MC; McKiernan JM
    BJU Int; 2005 Jan; 95(1):27-30. PubMed ID: 15638890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The changing evolution of renal tumours: a single center experience over a two-decade period.
    Patard JJ; Tazi H; Bensalah K; Rodriguez A; Vincendeau S; Rioux-Leclercq N; Guillé F; Lobel B
    Eur Urol; 2004 Apr; 45(4):490-3; discussion 493-4. PubMed ID: 15041114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic variables to predict cancer-related death in incidental renal tumours.
    Bensalah K; Pantuck AJ; Crepel M; Verhoest G; Méjean A; Valéri A; Ficarra V; Pfister C; Ferrière JM; Soulié M; Cindolo L; De La Taille A; Tostain J; Chautard D; Schips L; Zigeuner R; Abbou CC; Lobel B; Salomon L; Lechevallier E; Descotes JL; Guillé F; Colombel M; Belldegrun AS; Patard JJ
    BJU Int; 2008 Nov; 102(10):1376-80. PubMed ID: 18727618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of nephron-sparing surgery for T1b renal cell carcinoma.
    Joniau S; Vander Eeckt K; Srirangam SJ; Van Poppel H
    BJU Int; 2009 May; 103(10):1344-8. PubMed ID: 19040528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal tumors presentation: changing trends over two decades.
    Gupta NP; Ishwar R; Kumar A; Dogra PN; Seth A
    Indian J Cancer; 2010; 47(3):287-91. PubMed ID: 20587904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can we avoid surgery in elderly patients with renal masses by using the Charlson comorbidity index?
    O'Connor KM; Davis N; Lennon GM; Quinlan DM; Mulvin DW
    BJU Int; 2009 Jun; 103(11):1492-5. PubMed ID: 19076135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Does technical progress mean clinical advantage? Analysis of clinical and histopathological parameters of renal cell carcinomas in long-term course].
    Otto W; Hübner I; Burger M; Rössler W; Wieland WF; Denzinger S
    Aktuelle Urol; 2009 Sep; 40(5):303-6. PubMed ID: 19670107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of margin in nephron sparing surgery for renal cell carcinoma of 4 cm or less.
    Li QL; Guan HW; Wang FP; Jiang T; Wu HC; Song XS
    Chin Med J (Engl); 2008 Sep; 121(17):1662-5. PubMed ID: 19024095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephron sparing surgery is a feasible and efficient treatment of T1a renal cell carcinoma in kidney transplant: a prospective series from a single center.
    Chambade D; Meria P; Tariel E; Vérine J; De Kerviler E; Peraldi MN; Glotz D; Desgrandchamps F; Mongiat-Artus P
    J Urol; 2008 Nov; 180(5):2106-9. PubMed ID: 18804233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of repeat nephron sparing surgery as a treatment option in patients with a solid mass in a renal remnant.
    Magera JS; Frank I; Lohse CM; Leibovich BC; Cheville JC; Blute ML
    J Urol; 2008 Mar; 179(3):853-6. PubMed ID: 18221957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A decade of surgically removed small renal masses in the Netherlands: characteristics and trends in type of surgery and pathologic reporting.
    Kümmerlin IP; ten Kate FJ; Wijkstra H; Zwinderman A; de la Rosette JJ; Laguna MP
    J Endourol; 2010 Oct; 24(10):1675-9. PubMed ID: 20818987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Do broader indications for partial nephrectomy result in excess morbidity?].
    Verhoest G; Crepel M; Bernhard JC; Bellec L; Albouy B; Lopes D; Lacroix B; De La Taille A; Salomon L; Pfister C; Soulié M; Tostain J; Ferrière JM; Abbou CC; Colombel M; Vincendeau S; Bensalah K; Manunta A; Guillé F; Patard JJ
    Prog Urol; 2008 Apr; 18(4):207-13. PubMed ID: 18501300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients.
    Marszalek M; Meixl H; Polajnar M; Rauchenwald M; Jeschke K; Madersbacher S
    Eur Urol; 2009 May; 55(5):1171-8. PubMed ID: 19232819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
    Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
    BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidentally discovered renal masses: oncological and perioperative outcomes in patients with delayed surgical intervention.
    Rais-Bahrami S; Guzzo TJ; Jarrett TW; Kavoussi LR; Allaf ME
    BJU Int; 2009 May; 103(10):1355-8. PubMed ID: 19239459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transitional cell carcinomas of the renal pelvis and the ureter: comparative demographic characteristics, pathological grade and stage and 5-year survival in a Taiwanese population.
    Tan LB; Chang LL; Cheng KI; Huang CH; Kwan AL
    BJU Int; 2009 Feb; 103(3):312-6. PubMed ID: 18782312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.